BerandaAMLX • NASDAQ
add
Amylyx Pharmaceuticals Inc
Tutup sebelumnya
$6,50
Rentang hari
$6,15 - $6,59
Rentang tahun
$1,62 - $7,26
Kapitalisasi pasar
568,72Â jt USD
Volume Rata-Rata
1,08Â jt
Rasio P/E
-
Hasil dividen
-
Bursa utama
NASDAQ
Dalam berita
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | — | — |
Biaya operasional | 15,68Â jt | -72,85% |
Laba bersih | -35,91Â jt | 69,77% |
Margin laba bersih | — | — |
Penghasilan per saham | -0,42 | -242,05% |
EBITDA | -37,65Â jt | 69,09% |
Tarif pajak efektif | — | — |
Neraca
Total aset
Total liabilitas
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 204,07Â jt | -45,33% |
Total aset | 219,68Â jt | -47,38% |
Total liabilitas | 18,26Â jt | -80,37% |
Total ekuitas | 201,42 jt | — |
Saham yang beredar | 89,14 jt | — |
Harga terhadap nilai buku | 2,88 | — |
Tingkat pengembalian aset | -45,73% | — |
Tingkat pengembalian modal | -51,15% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -35,91Â jt | 69,77% |
Kas dari operasi | -39,82Â jt | -8.043,97% |
Kas dari investasi | -43,66Â jt | -5.430,77% |
Kas dari pembiayaan | 65,66Â jt | 50.023,66% |
Perubahan kas bersih | -17,62Â jt | -5.121,08% |
Arus kas bebas | -25,80Â jt | -4.555,82% |
Tentang
Amylyx Pharmaceuticals, Inc is a biopharmaceutical company headquartered in Cambridge, Massachusetts. Amylyx is best known for AMX0035, an experimental therapy for amyotrophic lateral sclerosis. AMX0035 was approved for medical use in Canada as Albrioza, in June 2022, and in the United States, as Relyvrio, in September 2022. It was withdrawn in April, 2024. Wikipedia
Didirikan
2013
Situs
Karyawan
123
